Air Force Institute of Technology

AFIT Scholar
Theses and Dissertations

Student Graduate Works

3-11-2011

Characterization and In Vitro Toxicity of Copper
Nanoparticles (Cu-NPs) in Murine
Neuroblastoma (N2A) Cells
Sitao Veronica Brownheim

Follow this and additional works at: https://scholar.afit.edu/etd
Part of the Environmental Engineering Commons
Recommended Citation
Brownheim, Sitao Veronica, "Characterization and In Vitro Toxicity of Copper Nanoparticles (Cu-NPs) in Murine Neuroblastoma
(N2A) Cells" (2011). Theses and Dissertations. 1520.
https://scholar.afit.edu/etd/1520

This Thesis is brought to you for free and open access by the Student Graduate Works at AFIT Scholar. It has been accepted for inclusion in Theses and
Dissertations by an authorized administrator of AFIT Scholar. For more information, please contact richard.mansfield@afit.edu.

CHARACTERIZATION AND IN VITRO TOXICITY OF COPPER
NANOPARTICLES (Cu-NPs) IN MURINE NEUROBLASTOMA
(N2A) CELLS

THESIS
Sitao Veronica Brownheim, Capt, USAF
AFIT/GES/ENV/11-M01

DEPARTMENT OF THE AIR FORCE
AIR UNIVERSITY

AIR FORCE INSTITUTE OF TECHNOLOGY
Wright-Patterson Air Force Base, Ohio
APPROVED FOR PUBLIC RELEASE; DISTRIBUTION UNLIMITED

The views expressed in this thesis are those of the author and do not reflect the official
policy or position of the United States Air Force, Department of Defense, or the United
States Government.
This material is declared a work of the United States Government and is not subject to
copyright protection in the United States.

AFIT/GES/ENV/11-M01

CHARACTERIZATION AND IN VITRO TOXICITY OF COPPER NANOPARTICLES
(Cu-NPs) IN MURINE NEUROBLASTOMA (N2A) CELLS

THESIS

Presented to the Faculty
Department of Systems and Engineering Management
Graduate School of Engineering and Management
Air Force Institute of Technology
Air University
Air Education and Training Command
In Partial Fulfillment of the Requirements for the
Degree of Master of Science in Environmental Engineering and Science

Sitao Veronica Brownheim, BS
Capt, USAF

March 2011
APPROVED FOR PUBLIC RELEASE; DISTRIBUTION UNLIMITED.

AFIT/GES/ENV/11-M01

CHARACTERIZATION AND IN VITRO TOXICITY OF COPPER NANOPARTICLES
(Cu-NPs) IN MURINE NEUROBLASTOMA (N2A) CELLS

Sitao Veronica Brownheim, BS
Capt, USAF

Approved:

//signed//
____________________________________
Dr. Charles A. Bleckmann (Chairman)

8/ March /2011

//signed//
____________________________________
Dr. Mark N. Goltz (Member)

8/ March /2011

//signed//
____________________________________
Dr. Amanda M. Schrand (Member)
Air Force Research Laboratory

4/ March /2011

//signed//
____________________________________
Dr. Saber M. Hussain (Member)
Air Force Research Laboratory

4/ March /2011

date

date

date

date

AFIT/GES/ENV/11-M01
Abstract
Nanomaterials, classified as materials within the 1 - 100 nanometer range, have
seemingly endless applications that can be beneficial to both the military as well as to the
greater society. Even with increased funding in recent years there is still a vast need for
characterization data from these materials in order to quantify risks to both humans as
well the environment. Nanomaterials are of great interest to the Air Force and the
military because of their many applications in munitions, sensing, electronics, and life
sciences including pharmaceutical drug delivery and medicine. Copper nanoparticles
(Cu-NPs) have already been considered for a range of uses based on their antimicrobial
properties and they are widely used in lubricants, inks and other applications that make
use of their anti-microbial properties. However, the biological effects of Cu-NPs can
vary based on their physicochemical properties; in particular, their oxide content and
primary size. Cu-NPs can be oxidized and exist as copper oxide nanoparticles (CuONPs). Also, larger size Cu-NPs can exist as micron-sized copper particles (Cu-MSP). It
is very important to the Air Force and especially the Bioenvironmental Engineering
career field to increase the understanding of Cu-NPs and the possible health impacts from
nanomaterial exposure prior to wide-spread industry and military use, particularly in
occupational settings.

Therefore, the purpose of this research is to thoroughly

characterize the properties of three different copper samples upon suspension into
aqueous solutions over time: Cu-NPs (Cu 25 nm), CuO-NPs (CuO 40 nm), and Cu-MSP
(Cu 500nm). Additionally, this research seeks to observe in vitro effects upon murine
neuroblastoma cells (N2A) by these three types of particles as well as by CuCl2.
Microscopy techniques indicate observable changes in oxidation for Cu-NP 25 nm and

CuO-NP 40 nm after suspension in water over long incubation.

In general,

agglomerations of the particles increase when dosed with the endocytosis inhibitor
Dynasore. In terms of cellular viability, CuCl2 is the least toxic at all concentrations.
Cu-NP 25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and
CuO-NP 40 nm. At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable
in toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.
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CHARACTERIZATION AND IN VITRO TOXICITY OF COPPER NANOPARTICLES
(Cu-NPs) IN MURINE NEUROBLASTOMA (N2A) CELLS

I.

Introduction

1.1 Background
Nanotechnology by definition means the creation and manipulation of materials at
the nanoscale level (1-100 nm) and is currently “experiencing massive, world-wide
investment as well as a tremendous rise in consumer products” (Schrand & Hussain,
2010). Nanotechnology is an important area of research for many reasons, including its
potential to transform many industries at phenomenal speeds.

Research in

nanotechnologies continues to expand worldwide everyday and the National Science
Foundation (NSF) estimates that nanotechnology will have a significant impact on the
global economy. Specifically, the National Institute for Occupational Safety and Health
(NIOSH) reports that nanotechnology will have an impact of over 1 trillion dollars and
employ over 2 million workers worldwide (NIOSH, 2009).
Despite all the research and development funds pouring in, much is still unknown
about potential hazards, safe handling practices, and effects on humans and the
environment of nanomaterials. There is also a growing concern for public safety as well
as ecosystem health.

1.2 Problem Identification

Cu Nanoparticles (Cu-NPs), Cu micron-size particles (Cu-MSPs) and Cu Oxide
Nanoparticles (CuO-NPs) are already in use as additives in inks, lubricants, and metallic
coatings. They are often emitted as particulates in smelters, metal foundries, and as torn
particles from asphalt and rubber tires (Midander et al., 2009).

With additional

applications in the future, there is still no clear understanding regarding their long-term
biological consequences. Only a few studies have attempted to thoroughly characterize
Cu-NPs, Cu-MSPs and CuO-NPs and investigate the toxicological effects of direct
exposure of cultured cells to these nano and micron-sized particles.

Additionally,

different physicochemical properties of the particles are likely linked to their toxicity.
Therefore, it is necessary to thoroughly characterize the particles prior to toxicity
assessment. Lastly, toxicity data are not typically extrapolated to account for different
sized particles. This needs to be accomplished, as particles agglomerate upon suspension
in aqueous environments.

1.3 Research Objectives
The purpose of this investigation was to thoroughly characterize Cu-NPs, CuMSPs and CuO-NPs upon their suspension in water and to determine the toxic effect of
these copper nanoparticles on Murine Neuroblastoma (N2A) Cells. Specifically, the
following issues were addressed:
1. Characterization of copper nanomaterial’s physiochemical properties
(morphology, shapes, agglomeration, spectral signature).

2.

Toxicity assessment of Cu-NPs, Cu-MSPs and CuO-NPs on the murine

neuroblastoma (N2A) cell line.

1.4 Research Focus
The focus of this basic research was limited to characterization of copper
nanoparticles and micron-sized particles and the in vitro exposure of murine
neuroblastoma cells to these copper nanoparticles.

The goal was to gain a better

understanding regarding the physicochemical properties of the copper nanoparticles prior
to in vitro toxicity testing for future modeling and in vivo exposure studies and ultimately
to develop recommended work place exposure limits.

1.5 Methodology
Prior to in vitro cell culture experiments, the effect of the cell culture media upon
the copper nanoparticles was investigated.

Previous research has demonstrated that

suspension of nanoparticles in cell culture media generally leads to the aggregation of
most compositions of nanoparticles (Murdock et al., 2008).
In vitro cell culture and aseptic techniques were used in this research. Murine
neuroblastoma (N2A) cells were cultured in T-75 plastic flasks and exposed to various
concentrations of Cu-NPs (25 nm), CuO-NPs (40 nm) and Cu-MSPs (500 nm) over
certain time periods. The viability of the N2A cells after exposure to each type of CuNPs, Cu-MSPs and CuO-NPs at various concentrations was determined by measuring the
mitochondrial function of the cell.

Mitochondrial function acts as an indicator of

metabolic activity and therefore also elucidates cell viability.
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The 3-(4,5-

dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay was used for the assessment of cellular viability based on mitochondrial
function.
Morphological characteristics of the cells after exposure to each type of Cu
particle, were observed with three different imaging techniques – two forms of Scanning
Electron Microscopy (SEM); high resolution and environmental, and two forms of
Transmission Electron Microscopy (TEM); high resolution and low voltage.
Agglomeration characteristics were observed by using Dynamic Light Scattering (DLS)
in dosing media along with the endocytosis inhibitor Dynasore.

1.6 Assumptions/Limitations
(1) The properties of Cu and CuO NPs and Cu micron particles were expected to
change after dry powder particles were suspended in water, dosing and
growth medias.
(2) Cells dosed at the same Cu particle concentration were equally exposed
throughout the experiment and that the exposure method used was
satisfactorily conducted.
(3) Studying the toxicity of copper particles using neuroblastoma cells as a model
has relevance to toxicity of the particles to humans.
(4) In Vitro results are limited and cannot be directly extrapolated without caution
to predict in vivo results.

1.7 Implications

Nanoparticles are used more and more widely in both consumer products and the
workplace. While researchers continue to study nanoparticles, a knowledge gap still
exists. We need to ramp up efforts to determine health exposure risks as well as potential
environmental effects. This research was conducted in order to elucidate copper nanoand micron-sized particles’ properties to aid in the evaluation of acceptable exposure
limitations in the occupational setting. Further investigations and measurements may
help define control requirements and regulations for these and other nanoparticles. With
the improved understanding and characterization of these particles we will be able to
better define negative health and environmental effects prior to wide-scale use, thereby
creating a healthier workplace environment for workers and consumers of nano- and
nanobiotechnology.

1.8 Overview of Document
This document contains five chapters.
Chapter Two: A review of selected literature on current and future uses of nanoparticles
including consideration for health and safety as well as an overview of copper toxicity.
The literature demonstrates that the toxicity of Cu-NPs, Cu-MSPs and CuO-NPs can be
characterized according to morphology, possibly size, cell viability assays, and studies
comparing the toxicity of Cu particles to that of other particles.
Chapter Three: Provides a concise explanation of the methods used to obtain data.
Chapter Four: Presents an analysis and possible interpretation of the data obtained.
Chapter Five: Draws final conclusions and suggests future research.
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II. Literature Review
2.1 Background
This literature review presents an overview on the basic background of
nanoparticles, the current societal uses of nanoparticles and relevant health and safety
considerations for the particles. A general summary of copper toxicity is provided as
well as relevant disease associations and environmental fate of these particles. The
literature review indicates that general conclusions can be drawn from cellular toxicity
experiments with copper and shows that toxicity can be somewhat characterized
according to cell viability, morphology, and size.

2.2 Nanoparticles (NPs)
Defined as particles with a diameter of less than 100 nm, nanoparticles are “a
heterogeneous group of materials that differ in many characteristics and physiochemical
properties, such as particle size, surface area, shape, morphology, elemental composition,
solubility, and agglomeration state” (Midander et al., 2009). Thus, in order to assess the
in vitro and in vivo toxicity of nanoparticles, a number of different characterization
methods are required.
The following illustration (Fig 2-1) provides examples of nanoarchitectures as
well as research that has led to the manipulation of nanomaterials. The comparison
between naturally occurring bio-structures and bio-molecules to manufactured
nanostructures demonstrates the progress made in developing manmade structures that
are comparable in size to the smallest natural materials.

Fig 1. Comparison of things found in nature to nanostructures/nanomaterials
The above "Scale of Things" chart was designed by the Office of Basic Energy Sciences
(BES) for the U.S. Department of Energy
(http://www.science.doe.gov/bes/scale_of_things.html)

The unique properties of nanoparticles are in large part a function of particle size.
Smaller particles have a much larger surface area-to-volume ratio as well as number of
particles in the same volume as compared to larger particles. Interestingly, this size
difference equates to enhanced inflammatory response and increased toxicity for many
nanoparticles when compared to larger particles of the same chemical composition
(Oberdörster et al., 2005a).
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From a toxicity perspective, the solubility of particles plays a two-fold role.
While more soluble particles, such as dissolved metal in ionic form, may contribute to
increased toxicity, more stable but less soluble forms of the metal may persist longer in
bio-systems and thus bio-accumulate

in both the organism and the environment

((Midander et al., 2009).
It is important to keep in mind that NPs are a heterogeneous group of materials
that can vary widely due to size, morphology, shape, surface area, elemental composition,
and solubility as well as agglomeration rate and sizes (Schrand and Hussain, 2010).
There are many different types of nanoparticles that can be categorized based upon their
composition into the following groups: 1) organic nanoparticles (e.g. polymers and
dendrimers), 2) inorganic nanoparticles (e.g. metallic nanoparticles), 3) organic/inorganic
hybrids (e.g. nanocomposites), 4) carbon based (e.g. functionalized fullerenes), 5)
liposomes (e.g. functionalized, inclusion complexes), and 6) biological nanoparticles (e.g.
protein and peptide- based nanoparticles with other biological components). Although
almost all of these types of NPs have potential beneficial applications for the military,
industry, and health sectors, there is still much unknown about potential hazards, safe
handling practices, and effects on humans and the environment. Adverse health concerns
include “cardiovascular and pulmonary diseases and an increased risk of developing lung
cancer” (Midander et al., 2009).

2.2.1 Current and Future Uses
It is not possible to cover all the various applications of nanotechnology. In order
to gain an understanding and appreciation for this area of research, a few specific

examples are highlighted here, including projected future uses.

Table 1 shows an

overview of some of the applications in nanotechnology (Schrand et al., 2010).

Table 1. Overview of Nanoparticle Types and Biotechnology Applications
Nanoparticle

Abbreviation

Application

Aluminum

Al

Fuel additive/propellant, explosive, wear resistant coating additive

Gold

Au

Cellular Imaging, Photodynamic Therapy

Iron (oxide)

Fe, Fe3O4, Fe2O3

Magnetic imaging, environmental remediation

Silica

SiO2

Fabrication of electric and thermal insulators, catalyst supports, drug carriers,
gene delivery, adsorbents, molecular sieves, and filler materials

Silver

Ag

Copper

Cu

Anti-microbial, Photography, Batteries, Electrical
Antimicrobial (ie. antiviral, antibacterial, antifouling, antifungal), antibiotic
treatment alternatives, nanocomposite coating, catalyst, lubricants, inks, filler
materials for enhanced conductivity and wear resistance

Cerium (oxide)

CeO2

Polishing and computer chip manufacturing , fuel additive to decrease
emissions

Manganese (oxide)

Mn

Catalysis, Batteries

Nickel (oxide)

Ni

Conduction, magnetic properties, catalysis, battery manufacture, printing inks

Titanium Dioxide

TiO2

Photocatalyst, Antibacterial coating, sterilization, Paint, Cosmetics,
Sunscreens

Zinc (oxide)

Zn, ZnO

Skin Protectant, Sunscreen

Nanotechnology may be the answer to our growing energy needs via the use of
high-efficiency organic photovoltaics (OPVs). Nanostructered thin films, “composed of
layers of semi-conducting organic materials (polymer or oligomers)” absorb photons
from the solar spectrum and make up the OPVs (Dingman, 2005). Because OPVs
composed of nanomaterials can be manufactured by a solution-based method they can be
made much more cheaply than “inorganic” counterparts. Still, challenges exist before
these devices can be mass produced, with the main concern being low solar energy
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conversion efficiencies. Another area of energy research is in the area of fuel cells,
because they are potentially more energy efficient than conventionally generated power.
Researchers have started to use nanomaterials in the catalyst layer of fuel cells as they
provide much larger active surface area due to their high surface areas. This increase in
active surface area equates to an increase in the catalytic rate of oxidation or reduction
while minimizing the amount of precious metals needed. In addition, researchers found
that “the electrocatalytic properties of the materials are sensitive to particle size, so
increased catalytic activity can be observed for nanoparticles and nanomaterials”
(Minteer, 2005).

However, one of the biggest benefits of using nanoparticles and

nanomaterials is that the weight of precious metals is greatly reduced, and thus cost is
also reduced. The need for a large amount of precious metals, thereby driving up cost,
has been the major limitation of fuel cells (Minteer, 2005).
Nanopowders and nanoparticle dispersions make very uniform coatings because
of their small and often homogenous size. Indium tin oxide and antimony tin oxide are
well known coatings that provide optical transparency and electrical conductivity to
materials. Examples of commercial uses include interactive touch screens and antistatic
coatings utilizing the conductivity of the nanoparticles to dissipate the static charge.
Nanoscale aluminum oxide and titanium oxide are also optically transparent and can
greatly decrease abrasion when compared to traditional coatings. Other coatings of
interest include zinc oxide and other rare-earth oxides that are also UV-reflective, but
optically transparent, thus providing protection of surfaces from degradation due to UV
exposures (Grocholl, 2005a).

Researchers have also been able to develop biosensors with near-infrared optical
capability. For example, single-walled carbon nanotubes (SWNT) are able to “modulate
their fluorescence emission in response to specific biomolecules” (Strano et al., 2005). A
SWNT coupled enzyme bio-conjugate was used to detect glucose concentration by
capitalizing on the fact that carbon nanotubes fluoresce in the near-infrared region and
that human tissues and biological fluids are transparent to their emission. The sensor can
then be employed to be excited by a near-infrared source from within the tissue and
provide continuous blood glucose levels by producing the appropriate fluorescence
response. The great potential benefit of this research is that the principle can be applied
to many other chemical systems in order to develop new types of sensors for use in both
medicine and biology (Strano et al., 2005).
SWNT have also been investigated for use in polymer composites. The main
issue with composites containing nanotubes is the poor solubility of SWNTs in polymers,
which can result in segregation. Therefore, successful SWNT composites require strong
adhesion between the polymer matrix and SWNT as well as uniform dispersion within
the matrix. In order to improve dispersion, coatings from surfactants and polymers are
used to achieve “a) tighter bonding with the grapheme surfaces, b) miscibility with
polymer matrixes of composites and c) substantially smaller concentration necessary for
the preparation of SWNT dispersions” (Kotov, 2005).
Novel nanotechnology methods use layer-by-layer (LBL) nanoassembly
composed of alternating oppositely charged polyelectrolytes, nanoparticles and proteins
to create ultrathin multi-layer nano-capsules for targeted drug delivery. Examples of
nanoparticles used successfully include different diameter and surface-charged gold,
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silica, nanoclay-montmorillonite, alumina and titanium dioxide. Nanoarchitects need a
wide variety of nanoparticles with varying properties and dimensions to proceed with this
type of research. Ideally, good candidate nanoparticles are “monodispersed, stable in
solution, charged nanoparticles of noble metals, metal oxides and ceramics with
diameters of 5, 10, 20, 50 and 100 nm” (Lvov, 2005).
Continuous carbon or boron fiber-reinforced aluminum and magnesium, as well
as silicon carbide reinforced aluminum belong in the category of metal matrix composites
(MMCs). These MMCs have already been used in aerospace applications mainly due to
their light weight and their ability to be tailored to possess specific properties. Metal
matrix nanocomposities have improved physical and mechanical properties when
compared to their micron-size counterparts. In addition, carbon nanotubes have “much
higher strength, stiffness, and electrical conductivity as compared to metals, and therefore
can significantly increase these properties of MMCs” (Rohatgi et al., 2005).
Another area of interest is reducing the cost of producing these materials. Most of
the research in synthesizing nanocomposites has involved the use of powder metallurgy
techniques. This method is not only expensive, but also easily contaminated. Other
methods of interest include stir mixing, squeeze casting and pressure infiltration that can
be both rapid and inexpensive in producing large quantities of components that are of
target sizes. Although there are still challenges in mixing nanoscale particles in metallic
melts mainly due to agglomeration, several research teams have shown that there are
dispersion techniques available (Rohatgi et al., 2005).
It is easy to recognize the importance of nanotechnology and nanomaterial
research just by the sheer amount of money being allocated to these fields. Lux Research

and the President’s Council of Advisors on Science and Technology (PCAST) have
shown that “the United States (US) is a global leader among governments funding
nanotechnology” (A Matter of Size: Triennial Review of the National Initiative, 2006). It
is important to keep in mind that it is complicated to compare nations’ spending on
nanotechnology due to differences in calculating and budgeting expenditures. Various
nations have different benchmarks in reporting what is public and private funding, how
researchers’ salaries are defined, etc. As seen in Fig 2-2, the United States leads in
nanotechnology research spending, although that position is being challenged. However,
according to Cientifica’s 2003 Nanotechnology Opportunity Report, Japan’s launch of
the Nano-Business Creation Initiative for creating new nanotechnology businesses in
Japan and building their foundation as nanotechnology leaders of the future indicate that
they also aspire to be a global leader in nanotechnology (A Matter of Size: Triennial
Review of the National Initiative, 2006).
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Fig 2. World nanotechnology funding, 2005. (Left) Nanotechnology funding globally by
source, 2005 (U.S. $ billion). (Right) Government nanotechnology funding by country,
2005 (U.S. $ million). SOURCE: Lux Research, Inc. 2006. The Nanotech Report. 4th
Edition. New York: Lux Research, Inc.

A more recent look at nanotechnology spending shows that more than 60
countries now have their own nanotechnology programs. These nations are most likely
following the lead of the United States, who announced establishment of the US National
Nanotechnology Initiative (NNI) in 2000. In 2010, nine years after the initiation of the
NNI, US federal spending dollars on nanotechnology has jumped from $464 million in
2001 to $1.8 billion (Shapira & Wang, 2010).
More spending in turn leads to more research publications. In fact, Shapira &
Wang (2010) identified more than 91,500 nanotechnology articles published between
August 2008 and July 2009 worldwide. However, even though the publications featured
researchers from 152 countries, 90% of the papers were written by authors from only 15
countries. The top four countries by author contribution are the United States (23%),
China (22%), Germany (8%), and Japan (8%) (Shapira & Wang, 2010).
As seen in Fig 2-3, while the US remains the focal point on the nanotechnology
map, US researchers partner with Chinese colleagues most often; although a strong
cluster of collaboration efforts are also seen with some European countries. However,
even after ten years since the launch of the NNI, only a small number of countries still
sponsor much of the world’s nanotechnology research; nanotechnology research has yet
to become a global activity. With competing technologies and limited funding, future

nanotechnology research will most likely not keep pace with the explosive growth of the
past decade.

Shapira and Wang (2010) recommend more high-quality international

collaborations for interested stakeholders to increase alliances with colleagues in other
countries.

Fig 3. A graphical depiction of nanotechnology research papers funded, with the node
size being proportional to the total number of papers (Shapira & Wang, 2010).

2.2.2 Uses of Copper Nanoparticles
In our recent medical history, fungal infections have become a major health
concern especially in immune-compromised patients such as those with acquired immune
deficiency and patients undergoing chemotherapy treatment.

Concurrently, copper

nanoparticles have been investigated for use in biotechnological applications that may
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one day combat some of these disease conditions.

For example, researchers have

combined copper nanoparticles with a polymer material to make a composite capable of
releasing metal species in a controlled manner in order to inhibit the growth of fungi and
other pathogenic microorganisms (Cioffi et al., 2005).
The germicidal properties of copper have been well recognized, in both its
particulate and soluble forms. Copper and copper oxide dispersions have been used in
maritime industries since the 19th century in antifouling coatings. The downside to this
application is the eventual mass release of copper compounds into the maritime system.
However, more recently, Cioffi et al. (2005) proposed a similar strategy as a way to
control the growth of saccharomyces cerevisiae yeast and molds through the use of
nanocomposites with spinning coatings that are equipped to release copper.

They

conclude that this nanostructured coating seem to be very promising as there is the
capability to control the metal release (Cioffi et al., 2005). Another area of interest is the
incorporation of low-copper-loading materials into packaging materials for food.
Furthermore, copper oxide nanopowder has also been suggested as an anti-microbial
preservative for use in wood and food products (Grocholl, 2005b).
In addition to controlling the growth of yeasts and molds, Cu-NPs have also been
shown to be effective in controlling the growth of bacteria such as Escherichia coli and
Bacillius subtilis. The theorized mechanism of Cu-NPs acting as an antibacterial agent is
“due to the interactions with the SH groups leading to protein denaturation” (Schrand et
al., 2010).
Manufactured nanosized copper particles have also been used as additives in
lubricants, inks, polymers and plastics, as well as metallic coatings.

They provide

excellent lubrication in oil due to mending effects and as an additive they reduce friction
as well as wear and tear on surfaces (Liu et al., 2004). In lithium ion batteries, nanosized
copper particles are deposited evenly onto graphite surfaces as an anode material (Guo et
al., 2002). Copper has also been used in various skin products to enhance healing and
prevent infection (Midander et al., 2009).

2.3 Health and Safety Considerations for NPs
As mentioned earlier, the National Nanotechnology Initiative (NNI) is a federal
interagency committee that was established in 2000 with aims to “expedite the discovery,
development, and deployment of nanotechnology in order to achieve responsible and
sustainable economic benefits, enhance the quality of life, and promote national security”
(A Matter of Size: Triennial Review of the National Initiative, 2006). The NNI has
outlined goals to ensure responsible development of nanotechnologies and the conduct of
responsible research. Some of NNI goals include carrying out research in order to
“characterize environmental, health, and safety (EHS) impacts of the development of
nanotechnology and assessment of associated risks”, educational efforts directed at
undergraduate programs and public outreach, and research aimed to identify and quantify
nanotechnology implications in a broader societal, economical, ethical, legal and
occupational contexts (A Matter of Size: Triennial Review of the National Initiative,
2006).
However, thus far, the committee has found that the Environmental, Health, and
Safety (EHS) effects data thus far produced by nanotechnology research are inconclusive.
The NNI state that risk assessments are poorly defined and need to be further developed.
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In addition, more research must be conducted to assess for EHS hazard potentials from
various nanomaterials. Ambiguous results were also obtained on the health and wellbeing of laboratory animals. Lack of in vitro and in vivo studies are partially to blame for
the deficiency in thorough characterization of nanomaterials. Achieving the goal of
obtaining valid and reproducible EHS data will depend on further research to produce
more specific risk-based guidelines. Until this goal can be met, the committee suggests
precautionary measures in order to protect all nanomaterial workers, the public, and the
environment.

Addressing the social and ethical challenges of nanotechnology will

involve the collaboration of scientists, engineers, toxicologists, and policymakers.
Throughout this national effort, it is important for the public to remain engaged in order
for risks to be adequately addressed and communicated and to ensure that
nanotechnology research is carried out in a responsible manner (A Matter of Size:
Triennial Review of the National Initiative, 2006).
As applications in nanotechnology continue to expand and consumers find more
and more nanoparticles in everyday products the area of health concerns will also gain
considerable attention. Thus far, most of the studies related to nanoparticles have been
focused on respiratory exposures. Other exposure routes including dermal and ingestion
have also started to be considered as potential routes of concern. A likely scenario for
ingestion to occur as a secondary route of exposure may involve mucociliary escalator
action where nanoparticles originally cleared by the respiratory tract are then ingested. In
addition, “nanomaterials can be ingested directly via water, food, cosmetics, drugs, drug
delivery devices, etc (Chen et al., 2006). Studies have also indicated that differing sized
nanoparticles may induce various toxicological effects after gastrointestinal intake.

2.3.1 Physicochemical Characteristics vs. Biological Activity
High surface area to volume ratio is a highly desirable aspect of nanoparticles,
such as in catalytic reactions, but one which can also have grave effects in terms of
toxicity. An analogy can be drawn from the ratio of surface area to volume of molecules
or atoms to that of the potential biological and chemical activity from nanoparticles.
With decreasing particle size, this ratio increases by orders of magnitude as seen in Table
2.
Table 2. Particle number and particle surface area per 10 µg/m³
airborne particles (Oberdörster et al., 2005b).
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As seen in Table 2, surface molecules are plotted as a function of particles’
diameters. At less than 100 nm, surface molecules increase exponentially with a decrease
in particle diameter. This results in a massive increase in chemical and biological activity
potential. It is important to understand that this is a two-sided issue. On the one hand,
increased biological activity can be very beneficial for “antioxidant activity, carrier
capacity for therapeutics, and penetration of cellular barriers” (Oberdörster et al., 2005b).
However, toxicity and oxidative stress of cellular functions may also dramatically
increase.

2.3.2 Benefits vs. Occupational Exposure Risks
While the benefits of nanoparticles are indeed promising, the many useful
properties of nanoparticles (size, surface area, reactivity) also pose a number of risks.
Currently, a rising number of workers are potentially exposed to nanomaterials in
“research laboratories, start-up companies, production facilities, and in operations where
nanomaterials are processed, used, disposed or recycled” (Howard, 2005).

Many

challenges remain in the determination of potential negative health effects and
occupational safety risks from working with intentionally produced and engineered
materials and devices.

But the larger goal is to realize potential benefits of

nanotechnology research while being meticulously careful in minimizing risks associated
with these endeavors (Howard, 2005).

2.3.2 Regulations

In terms of regulation requirements set forth for nanomaterials the issue is
somewhat unclear.

The EPA has mainly focused its efforts towards regulating

nanomaterials through the Toxic Substances Control Act (TSCA) where most materials
are considered as chemical substances.

The regulatory approach used by the EPA

follows a four-pronged approach that includes the following: pre-manufacture
notifications, a significant new use rule, an information gathering rule, and a test rule
(TSCA, U.S. EPA, 2011).
Prior to the manufacturing of new chemical substances, companies must provide
specific information to the EPA as required by TSCA. The EPA then takes action to
ensure that human and environmental contamination risks are minimized. The EPA
provides assistance to manufacturers when determining whether their nanomaterials fall
under the new chemical category. Since 2005 the EPA has reviewed over 100 new
notifications for nanomaterials, and this number is expected to continue to rise. The
agency has taken a number of actions including “limiting the uses of the nanoscale
materials, requiring the use of personal protective equipment, such as impervious gloves
and NIOSH approved respirators, limiting environmental releases, and requiring testing
to generate health and environmental effects data” (TSCA, U.S. EPA, 2011).
It is important to note that there are exceptions made for certain manufacturers of
new nanomaterials under certain conditions where possible exposures are very tightly
controlled and risks are minimized to include environmental releases. Another proposed
rule developed under TSCA section 8a requires submission of additional information
from manufacturers such as production volume, methods used, exposures and any
relevant release information and all available safety data. Lastly, under TSCA section 4
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the EPA proposed a testing rule for certain nanomaterials already in use. Any new
information on nanomaterials not already being tested by other Federal agencies would
enable the agency to further understand any novel toxicity data that link certain chemical
and physical characteristics to in vitro and in vivo toxicity (TSCA, U.S. EPA, 2011).

2.3.2 Future Concerns and Funding
The NIOSH Nanotechnology Research Center (NTRC) was established in 2004
largely due to the anticipated increase in current as well as future nanotechnology
research developments and to study potential worker exposures. NIOSH scientists form
the bulk of NTRC researchers engaged in developing future NIOSH guidelines in
nanotechnology health research. A far-reaching collaboration effort from the combined
efforts of government agencies, academia and the private sector has aided the
development of a NIOSH strategic plan in nanotechnology research and guidance
(Howard, 2005).
The strategic plan’s goals are as follows:
1. Determine if nanoparticles and nanomaterials pose risks for work-related
injuries and illnesses.
2. Conduct research to prevent work-related injuries and illnesses due to
nanotechnology products.
3. Promote healthy workplaces through interventions, recommendations, and
capacity building.
4. Enhance global workplace safety and health through national and international
collaborations on nanotechnology research and guidance.

The NIOSH Office of Extramural Programs (OEP) works with the research
community and awards grants in occupational safety and health grants. To date, OEP has
committed roughly 5.3 million dollars to nanotechnology research. NIOSH also joined
with the Environmental Protection Agency as well as the National Science Foundation in
2004 and committed $7 million in funding of grants in continued research (Howard,
2005).

2.3 Copper Toxicity
As a naturally occurring metallic compound, copper may exist by itself or may be
associated with other elements. Copper particulates released into the air may be from
both natural and anthropogenic sources. Volcanic eruptions are the main natural source
of windblown copper particulates in dust. Copper smelters or other ore processing
facilities are sources of copper particulates from manufacturing processes. Many times
copper particles are removed from the atmosphere by precipitation, but they can be easily
re-suspended in the form of copper dust. In the U.S., the mean ranges of copper in the
ambient air can vary widely, from 5 to 200 ng/m³ (ATSDR, 2004).
Copper releases into the waterways usually occur via natural weathering of soil
and rocks or from anthropogenic sources such as the effluent of industries or sewage
treatment plants. Copper concentrations in drinking water may vary depending on pH
and hardness of the local water. Copper values in soil vary from 5 to 70 mg/kg and the
estimated daily value of ingestion intake of copper from food is 1.0-1.3 mg/kg for adults
(0.014-0.019 mg/kg/day). The Food and Nutrition Board of the Institute of Medicine
recommend dietary allowance (RDA) of “340 micrograms (μg) of copper per day for
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children aged 1–3 years, 440 μg/day for children aged 4–8 years, 700 μg/day for children
aged 9–13 years, 890 μg/day for children aged 14–18 years, and 900 μg/day for adults”
(ATSDR, 2004).
Copper is a necessary trace element in the body, and mechanisms have evolved
for the use, transport, and excretion of copper from the body. Copper is an essential
nutrient because it is incorporated as one of many metalloenzymes necessary for proper
hemoglobin formation, carbohydrate metabolism, collagen, elastin and hair keratin,
antioxidant defense, etc,. Normal copper absorption occurs from the stomach and small
intestine. Complexing molecules have been known to exist in blood, but researchers
have only been able to discover cellular copper transporters in the last decade or so. For
those individuals lacking the proper copper exporter pump, diseases such as Menkes or
Wilson’s diseases result (Nordberg et al, 2007).

2.4.1 Environmental Contamination
As manufactured nanomaterial use increases in many commercial products,
concerns have been raised regarding environmental release and contamination. Because
of their highly reactive nature, nanoparticles differ in many physical and chemical
characteristics from their metallic ion counterparts.

Ganesh et al. (2010) evaluate

nanocopper removal and the related toxicity in municipal wastewaters. They note that
wastewater treatment plants are most likely the last barrier to any nanomaterial release
into the environment. It is important to note that because of aforementioned differences
of nanoparticles from metal ions, they also behave differently in biosolids. In fact,

wastewater effluents models have already detected nanomaterial presence (Ganesh et al.,
2010).
Ganesh et al. (2010) conducted two sets of experiments evaluating copper
nanoparticle and copper ion removal, one with normal activated sludge microorganisms
and one with activated sludge filtrates that did not contain biomass. The objective was to
observe the amount of copper removal without the aid of biosorption. For the first
experimental condition, approximately 30-70% of copper ions were removed. Cu NPs
were removed at a higher percentage of around 90%. Interestingly the team observed
that nearly 25-55% of copper ions and 75-80% of CuNPs were removed in the activated
sludge filtrates without biomass.

This indicates that copper biosorption was not a

significant mechanism of copper removal.
This preliminary study gives only rudimentary understanding of the fate and
transport of CuNPs during wastewater treatment; other impacts including long-term
effects are unknown. Further concerns include changes to the microbial community of
the activated sludge that may result from prolonged exposure to CuNPs.

Other

mechanisms may take place, further altering CuNPs and other nanomaterials at the point
of environmental release and during sludge handling and ultimately disposal. Lastly, it
was found that all residual samples of copper violated the National Toxics Rule (NTR)
criteria for wastewater discharge of 8.9 µg/L (Ganesh et al., 2010).

2.4.2 Exposure and Human Disease
Many studies have found a number of systemic effects including gastrointestinal,
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hepatic, as well as renal effects following acute, intermediate, and chronic exposures to
copper and an extensive database exists on the toxicity of ingested copper in animals,
including immunological and developmental effects.

However, several studies have

attempted to investigate potential neurological and reproductive targets, without
conclusively finding any effects (ATSDR, 2004).
The general population comes in contact with copper through ingestion of food
and water, and dermal contact with air, water or soil that contains copper. Although
contact primarily occurs from intake, the amount of copper uptake is usually less than the
average dietary requirements (RDAs) for copper. Inhalation of copper is a concern for
individuals living near copper smelters or other refineries. Workers in these facilities
may experience high occupational exposures to copper.

Another concern is young

children ingesting soil with high levels of copper while living near these facilities. The
EPA has identified copper hazards at 906 of 1,647 hazardous sites on the EPA’s National
Priorities List (EPA NPL) (ATSDR, 2004).
Ingestion of excess copper is a concern because copper is easily absorbed from
the stomach and the small intestine. There are, however, several mechanisms for dealing
with copper overload. Excess copper that is absorbed in the intestinal mucosal cells
binds to the metal binding protein metallothionein. When the mucosal cells slough off
the copper is also excreted. The remaining copper in the system is then transported to the
liver, and then becomes a part of the bile that will ultimately be excreted in feces.
Copper homeostasis can be fairly effective in the body. However, excess copper can
result in serious damage to the body including “liver and kidney damage, anemia,
immunotoxicity, and developmental toxicity” (ATSDR, 2004).

Excess copper that

cannot be mediated by homeostatic processes of the body will even bind with several
enzymes to interfere with the protective mechanisms of cells from free radical damage
(ATSDR, 2004).
For drinking water, the EPA has determined that it should not contain more than
1.3 mg of copper per liter of water (1.3 mg/L). The Occupational Safety and Health
Administration (OSHA) has set a limit of “0.1 milligrams/cubic meter (mg/m3) for
copper fumes (vapor generated from heating copper) and 1.0 mg/m3 for copper dusts
(fine metallic copper particles) and mists (aerosols of soluble copper) in workroom air to
protect workers during an 8-hour work shift (40-hour workweek)” (ATSDR, 2004).

2.4.2.2 Respiratory and Gastrointestinal Distress
While copper can be irritating to the respiratory tract, the most commonly
reported adverse health effect is gastrointestinal distress. Workers routinely exposed to
copper dust have reported increased coughing, sneezing, running nose, fibrosis and
generally increased vascularity in the nasal cavity. Nausea and abdominal pain have been
reported after drinking fluids high in copper, stagnant water from a first-draw copper pipe
(such as first thing in the morning without any flushing of the water), or beverages stored
in a copper container (ATSDR, 2004).

2.4.2.3 Nervous System Effects & Neurological Disorders
Murthy et al. (1981) conducted a study by administering either manganese
chloride (1 mg manganese/mL drinking water) or copper sulfate (250 mg copper/kg food)
to growing rats for 30 days. The rats are normally maintained on a 10% casein diet.
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Neurobehavioral performances remained the same for the rats exposed only to copper in
their diets but the combined exposure to copper and manganese produced elevated levels
of dopamine and norepinephrine and a depression of 5-hydroxytryptamine, a dopamine
metabolite.

These changes suggest that copper may adversely affect the nervous system

but the study was inconclusive and suggested that further research be conducted to
investigate the neurotoxic potential of copper (Murthy et al., 1981).

2.5 Neuroblastoma in Humans
The cells used in the cellular experiments were Murine Neuroblastoma (N2A)
cells. Neuroblastoma in humans, occurs mostly in infants and children and is a cancerous
tumor that develops from nerve tissues. Since nerves run throughout the body, this
disease can also occur in many areas of the body. Neuroblastoma tumors usually develop
in tissues forming the sympathetic nervous system (PubMed Health, 2011).
For children less than 15 years of age, sympathetic nervous system tumors
account for 7.8% of all tumors, with most of the cases being neuroblastomas.
Neuroblastomas are also the most common cancer of infancy, with double the incidence
rate of the next most common disease in the first year of life: leukemia (National Cancer
Institute, 2011). Most of the tumors originate in the adrenal gland in the abdomen, close
to the spinal cord, or sometimes in the chest area. Unfortunately, the disease can easily
metastasize to other regions, including bones of the extremities, head, pelvis, and
shoulders as well as bone marrow, liver, skin, and lymph nodes (PubMed Health, 2011).
Survival for children diagnosed at age 1 to 4 is 83% and 40% for those 5 years or
older. The cause of neuroblastoma is largely unknown. Certain medications, maternal

use of alcohol and tobacco and paternal occupational hazards have associations, but these
are not clear (National Cancer Institute, 2011). The diseases occur slightly more in boys
than girls.
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III. Methodology
3.1 Introduction
The goal of this research was to characterize three copper nano and micron-sized
particles and observe the particles’ relevant toxicity effects on N2A cells.

The

characterization was carried out using a series of methods and equipment. Malvern’s
Zetasizer was used for Dynamic Light Scattering (DLS) to characterize the average size
of agglomerates in the dosing media. A dark-field microscope with Cytoviva as a light
source and using the Hyperspectral Imaging (HSI) technique was used for verifying that
the particles are indeed copper particles by analyzing the spectra collected by the
spectrophotometer. The Low Voltage Electron Microscope (LVEM), Environmental
Scanning Electron Microscope (ESEM), Scanning Electron Microscope (SEM) and
Transmission Electron Microscope (TEM) were used to observe surface morphology
changes that the particles experience over time while suspended in water, oxidation
changes on particle surfaces, uptake of particles into N2A cells, and also confirmation of
sizes as well as any possible changes in particle size over time.

The 3-(4,5-

dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay was used for the assessment of cellular viability based on mitochondrial
function for the Cu-NP 25 nm, CuO-NP 40 nm, Cu-MSP 500 nm, as well as CuCl2.

3.2 Assumptions
Several key assumptions were made at the beginning of the laboratory experiments.

(1) The properties of Cu and CuO NPs and Cu micron particles were expected to
change after dry powder particles were suspended in water, dosing and
growth medias.
(2) Cells dosed at the same Cu particle concentration were equally exposed
throughout the experiment and that the exposure method used was
satisfactorily conducted.
(3) Studying the toxicity of copper particles using neuroblastoma cells as a model
has relevance to toxicity of the particles to humans.
(4) In Vitro results are limited and cannot be directly extrapolated without caution
to predict in vivo results.

3.3 Cell Line
The Neuro-2a (N2A) line was obtained from the American Type Culture
Collection (ATCC). Clone Neuro-2a was derived by R.J. Klebe and F.H. Ruddle from a
spontaneous tumor of a strain A albino Mus musculus, or mouse.

These cells are

adherent type cells, and their morphology is described as neuronal and amoeboid stem
cells. The disease that these cells would eventually manifest to would be neuroblastoma
in the organism. ATCC product description indicates that this tumor line produces large
quantities of microtubular protein which researchers believe “play a role in a contractile
system which is responsible for axoplasmic flow in nerve cells” and that the World
Organization for Animal Health (OIE) routinely uses these cells for the diagnosis of
rabies (ATCC, 2011). These cells were chosen because they provide a neuronal model,
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bringing a different perspective than the more commonly studied macrophages or
keratinocytes.

3.4 Cell Culture
Cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)
nutrient mixture F-12 Ham’s and supplemented with 10% Fetal Bovine Serum (FBS),
received from American Type Culture Collection (ATCC, Manassas, USA).

1%

Penicillin-Streptomycin, received from American Type Culture Collection (ATCC,
Manassas, USA) was added to the growth media. DMEM was freshly prepared from
powder form and preparation instructions were followed from Sigma-Aldrich’s product
information page (Sigma-Aldrich, DMEM, 201). Fetal Bovine Serum is widely used as a
growth supplement for cell culture use mainly due to its high content of embryonic
growth promoting factors.

From Sigma-Aldrich, “when used at appropriate

concentrations it supplies many defined and undefined components that have been shown
to satisfy specific metabolic requirements for the culture of cells” (Sigma-Aldrich, 2011).
Penicillin-Streptomycin (pen strep) is a broad-spectrum bactericide effective against both
gram negative as well as gram positive bacteria. Upon thawing its activity decreases.
Therefore, it’s best that it is thawed shortly before use (Lonza, 2011).

3.4.1 Cell Maintenance
Cell maintenance was conducted to ensure healthy cells were always available for
experiments. Detailed cell care instructions are given in appendices A and B.

3.4.2 Cell Count/Cell Volume
In order to measure and compare results, and to ensure quality imaging, cells must
be plated at certain concentrations. Unless otherwise noted, all cells are plated in 96-well
plates at 150K cells per mL. Nexcelom Bioscience’s Cellometer Vision was used for
automated cell counts. Samples can also be adjusted to the desired concentration in the
program (Nexcelom Bioscience, 2011).

3.5 Biotek Synergy HT
The water-soluble formazan product produced by active mitochondria in live cells
was quantified with the Biotek Synergy HT plate reader in the MTS assays. The plate
reader measured emitted light at 490 nm wavelengths for the MTS assay. A reading at
“0” minutes was also taken and then subtracted from the final reading to account for any
background absorbance due to the nano or micron-sized particles or the solution. The
percent reduction of MTS was then compared to the control cells not exposed to
treatment, which represented 100% of MTS reduction.

3.6 Nanoparticles
The test materials, Cu-NPs (small metallic Copper nanoparticles 25 nm, small
oxidized Copper nanoparticles 40 nm in diameter) and Cu micron-sized particles (large
Copper particles at 500 nm in diameter) were supplied by American Elements. The Cu
nano and micron particles, in dry powder form, were suspended in de-ionized water to
make stock solutions (1 mg/ml). Prior to each use, stock solutions were sonicated to
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reduce agglomeration of particles. Agglomeration was characterized with the Olympus
IX71 inverted fluorescent microscope with CytoViva as a light source (Appendix G).
Fresh dilutions were made for each specific experiment from stock solutions and
the appropriate concentrations were obtained by mixing the appropriate amount of stock
solution with dosing media. Details for each copper concentration (dose) are given in
future sections. Tables 3 and 4 categorize nanoparticles by source, size, assay use, and
dosing range. Other dosing concentrations are given specifically for the specific result
reported in the results section.
Table 3. Nanoparticles Used
Chemical

Size (diameter)

Source

Uses

Cu

25 nm

American Elements

Characterization, MTS Assay

CuO

40 nm

Sigma Aldrich

Characterization, MTS Assay

Cu

400 nm

American Elements

Characterization, MTS Assay

Novacentrix

MTS Assay

CuCl2

Particle
Cu
25 nm
CuO
40 nm
Cu
500 nm
CuCl2

Table 4. Nanoparticle Dosing (0, 5, 10, 25, 50, 100 µg/mL media) (10% FBS) (1%
Penicillin-Streptomycin) for MTS Assay
0 µg/mL 5 µg/mL
10 µg/mL
25 µg/mL
50 µg/mL
100 µg/mL
3 mL of 15 µL Cu 25 30 µL Cu 25 nm 75 µL Cu 25 nm 150 µL Cu 25 300 µL Cu 25 nm
dosing
nm + 2985 µL +
2970
µL + 2925 µL dosing nm + 2850 µL + 2700 µL dosing
media
dosing media
dosing media
media
dosing media
media
3 mL of 15 µL CuO 40 30 µL CuO 40 75 µL CuO 40 150 µL CuO 40 300 µL CuO 40
dosing
nm + 2985 µL nm + 2970 µL nm + 2925 µL nm + 2850 µL nm + 2700 µL
media
dosing media
dosing media
dosing media
dosing media
dosing media
3 mL of 15 µL Cu 500 30 µL Cu 500 75 µL Cu 500 nm 150 µL Cu 500 300 µL Cu 500
dosing
nm + 2985 µL nm + 2970 µL + 2925 µL dosing nm + 2850 µL nm + 2700 µL
media
dosing media
dosing media
media
dosing media
dosing media
3 mL of 15 µL CuCl2 + 30 µL CuCl2 +
75 µL CuCl2 +
150 µL CuCl2 + 300 µL CuCl2 +
dosing
2985 µL
2970 µL dosing
2925 µL dosing
2850 µL dosing
2700 µL dosing
media
dosing media
media
media
media
media

3.7 MTS Assay
The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium (MTS) assay is a colorimetric method for the assessment of cellular
viability based on mitochondrial function. The assay consists of the novel tetrazolium
compound and an electron coupling reagent phenazine methosulfate (PMS).

Cells

bioreduce the MTS into a formazan product that is tissue culture soluble. This chemical
conversion process can be seen in figure 3-1 below. The absorbance of the formazan
product was measured at 490 nm directly from the 96-well assay plates.

Figure 4. Structure of MTS tetrazolium salt and the formation of the Formazan product.
(“Cell Titer 96® Aqueous Non-Radioactive Cell Proliferation Assay”, Promega, 2009).

Four 96 well plates of N2A cells were treated with the three types of Cu particles
as well as CuCl2. The same amount of dosing media was placed in cell wells to be used
as controls. After 180 minutes of treatment and incubation with the copper particles the
MTS was added to all the cell wells. At “0” time a reading was taken at 490 nm as a
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background. After an hour of incubation with the MTS agent, a dark purple color
developed within the cells, indicating the formation of a water-soluble formazan product
by active mitochondria in live cells. The formazan product was quantified with a
microplate reader at 490nm. A “0” minute reading was then subtracted out of the final
reading to account for background absorbance due to the NPs or the solution. The percent
reduction of MTS was compared to controls (cells not exposed to particles), which
represented 100% MTS reduction.
The MTS experiment was then repeated, but this time with a 1 hour pre-treatment
with the endocytosis inhibitor Dynasore. More information on Dynasore can be found in
section 3.8.5 along with the Dynamic Light Scattering technique. This experiment was
conducted in order to eliminate con-founders and determine whether pre-treatment with
Dynasore can increase cell viability prior to Cu exposures.

3.8 Characterization
Characterization of the copper particles was conducted in a series of phases using
different techniques. The goal of characterization was to study particle morphology and
surface oxidation in “dry” as well as “wet” conditions. A series of techniques were used,
beginning with the Low-Voltage Electron Microscope (LVEM) and proceeding to the
Environmental Scanning Electron Microscope (ESEM), the Scanning Electron
Microscope (SEM), the high resolution Transmission Electron Microscope (TEM),
Dynamic Light Scattering (DLS), and finally Hyperspectral Imaging (HSI), in turn.

3.8.1 LVEM
Low Voltage Electron Microscopy was conducted for the Cu-NP 25 nm, CuO-NP
40 nm, and Cu-MSP 500 nm. The LVEM is designed for a broad range of applications in
many fields to include biology, medicine and material science and provides valuable
capabilities in nanotechnology and organic materials. High contrast is achieved by using
much lower electron energy at 5 keV compared to the high resolution TEM and as a
result there is additional electron scattering resulting in better contrast (Schrand and
Hussain, 2010).
The LVEM was used as a basic tool to observe the particles and provide an
estimate of the sizes of the particles. It serves as a preliminary scan and gives a basic
view of the general shapes of the particles. The LVEM is under high vacuum but uses
low voltages. The table-top set up also provides for ease of use.

3.8.2 ESEM
The ESEM was used to better observe morphology. It is a unique instrument as
the samples can be studied with it while they are somewhat “wet”. Limited surface
morphology can be observed. The ESEM permits increased magnification of images but
operates under low vacuum conditions.

3.8.3 SEM
An experiment evaluating N2A cells exposed to various copper particles as well
as CuCl2 was conducted. The N2A cells were seeded on glass cover slips and allowed to
grow for about 24 hours or when they looked fairly confluent and healthy. Samples were
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then exposed to the particles or CuCl2 for 3 hours and then washed and dried. Samples
were then prepared for imaging at the Materials Lab. Further details on this protocol can
be found in appendix E.

3.8.4 TEM
Dry characterization was conducted using the high resolution TEM.

Cu

Nanoparticles (Cu-NPs) (25 nm), Cu micron-size particles (Cu-MSPs) (500 nm) and Cu
Oxide Nanoparticles (CuO-NPs) (40 nm) were freshly suspended in water and prepared
for TEM imaging at the “0” time point. Samples of each type of particle were then
imaged again at a short term incubation time point (2 or 3 months) and again at a long
term incubation time point (6 months).

This incubation time point imaging was

conducted in order to look for general morphology changes, as well as surface
morphology changes and surface oxidation changes.

3.8.5 Dynamic Light Scattering
Prior to any experimentation with the N2A cells, it was important to learn about
the behaviors of the particles in dosing media, replicating the conditions the cells would
experience while being dosed. In order to understand biochemical interactions, it was
necessary to investigate solution agglomeration of particles. Agglomeration of particles
may interfere with cellular uptake by processes such as phagocytosis or pinocytosis. To
eliminate possible confounding factors due to bio-molecule size, only dosing solution
(without FBS) was added to formulate solutions for measurements.

To do this, Malvern’s Zetasizer was used to conduct dynamic light scattering of
the Cu particles. In order to understand whether the cells would uptake the particles, it is
necessary to study particle behavior and agglomeration in just the dosing media alone as
large agglomerates would not be able to cross the cell membrane. The Zetasizer DLS
instrument measures particle size by looking at the diameter of the sphere that diffuses at
the same speed as the particle being measured.

The instrument first measures the

Brownian motion of the particles and then interprets this data using the Stokes-Einstein
equation to determine the relationship between the size of the particle and its speed due to
the Brownian motion. The particles are in constant motion, and the speckle pattern that is
created will also appear to move. Constructive and destructive phases of the scattered
light will in turn cause bright and dark areas. These areas grow and diminish in intensity
and will appear to fluctuate. The DLS system measures this rate of fluctuation and uses
this information to calculate the size of the particles (Malvern Zetasizer Manual, 2009).
The Cu particles were freshly prepared from stock solutions to arrive at final
concentrations of 25 ug/mL, 50 ug/mL and also 100 ug/mL and added to 25 µM of
Dynasore, an endocytosis inhibitor. Dynasore, an endocyctosis inhibitor, is co-incubated
with the particles because current research shows that it may potentially aid cell viability
while the cell is dosed with Cu nanoparticles (Schrand et al., In Preparation).
Specifically the addition of Dynasore increases viability of cells dosed with metallic
forms of Cu at high doses (>50 µg/ml).
From studies conducted by Schrand et al. (In Preparation), it was discovered that
both small and large metallic Cu- NPs are more toxic than the CuO-NPs. Additionally,
CuO-NPs are not toxic after 3h of exposure and are also not affected by the presence or
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absence of the endocytosis inhibitor. This observation poses the possibility that if the
chemical modulator can affect the N2A cells in some way, either by preventing the
particles from being up-taken or changing the shape or size of the particles, then the
cytotoxicity of the Cu particles are lessened on the cells. In this research, it is reasonable
to suggest that any alterations in physiochemical properties after incubation with
Dynasore would therefore be apparent.
It was also shown that the manufactured nanoparticles were not always in the size
ranges claimed. For Cu-NP “25 nm” was measured to have an average size of 88 ±
30nm, CuO-NP “40 nm” was measured to have an average size of 78 ± 21nm, and CuMSP (500 nm) had an average size of 477 ± 184nm (Schrand et al., In Preparation).
However, for the experiments described here the original manufactured sizes will be used
to designate the particles, but with the understanding that the nominal size does not
represent the actual size.
3-Hydroxynaphthalene-2-carboxylic acid (3,4 dihydroxybenzylidene) hydrazide,
or Dynasore, is a non-competitive inhibitor of dynamin 1, dynamin 2 and mitochondrial
dynamin (Drp1) GTPase activity. Dynamin is essential for clathrin-dependent coated
vesicle formation and is “required for membrane budding at a late stage during the
transition from a fully formed pit to a pinched-off vesicle” while Dynasore is able to
block the endocytic pathways that are dependent on dynamin and blocks vesicle
formation within seconds of being added (Macia et al., 2006).
Figure 3-2 shows the chemical structure of Dynasore. Previous experiments
showed that there was a limited increase in viability of cells that were pre-treated with
Dynasore prior to NP exposure (Schrand et al, In Preparation).

Fig 5. Chemical structure of Dynasore (Tocris Bioscience, 2010).

3.8.6 Hyperspectral Imaging (HSI) using Cytoviva®
The Hyperspectral Imaging system using Cytoviva as a light source provides a
spectral analysis of nanomaterials in the visible near infrared spectral range (VNIR), from
400 to 1000 nm. While not used in this research, the HSI system can analyze for both
non-fluorescent and fluorescently labeled components in live cells and nano-materials,
enabling a wide range of capabilities for bio-medical research in both cell biology and
infectious disease research (Cytoviva, 2011).
Hyperspectral Imaging (HSI) was conducted on control N2A cells as well as on
each of the three particle types (Cu-NP 25 nm, CuO-NP 40 nm, Cu-MSP 500 nm).
Copper nano and micron-sized particles scatter colored light when illuminated with white
light (the Cytoviva light source). A concentric imaging spectrophotometer collects the
spectra from each particle type.
Many metallic nanoparticles are able to support surface plasmons at optical
frequencies. These plasmons are known as localized surface plasmons (LSPs). It is due
to the recent understanding of the nature of these plasmons combined with their refractive
index sensitivity that has led to using nanoparticles as biosensors (Miller and Lazarides,
2005).
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When a particle is struck by an electromagnetic wave, the electrons of the particle
will oscillate at the frequency of the incident wave and an oscillating electron will radiate
at the same electromagnetic radiation as the oscillating electron. It is from this secondary
radiation that the scattering of light occurs. Since light scattered by a particle illuminated
from a monochromatic light source has the same wavelength as the incident light the
distinct scattered colors coming from different particles and varying sizes can only be
produced when the source (illuminating) light is a polychromatic white light. This
polychromatic white light is “produced by a filament lamp operated at high color
temperature” and the scattering of colors results because each type of particle will
preferentially scatter light over a narrow wavelength band. Nanoparticles differing in
composition, shape, size, and homogeneity as well as their medium refractive index will
alter the respective particles’ light-scattering properties (Yguerabide and Yguerabide,
1998).
Yguerabide and Yguerabide (1998) show that copper particles display a weak
scattering band around the 380 to 550 nm region in Table 5. This can also seen in Fig 33, where “the light-scattering power of a particle can be expressed in terms of the lightscattering cross section” versus the various wavelengths from light scattered by various
particles (Yguerabide and Yguerabide, 1998).

Fig 6. Graphs of light-scattering cross section vs. wavelength for various particles.
(Yguerabide and Yguerabide, 1998).

Table 5. Calculated Light-Scattering and Absorption Properties for Various Particles
(Yguerabide and Yguerabide, 1998).
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3.9

Statistical Analysis
Statistical Analysis was performed for the MTS data as mean ± standard

deviation.

IV. Data Description and Analysis
4.1 Introduction
This Chapter presents the data gathered from the methodologies described in
Chapter 3. The chapter includes, in this order: 24 hour exposure MTS data of N2A to
Cu-NPs, Cu-MSPs and CuO-NPs, and CuCl2, DLS experimental data, LVEM images,
ESEM images, SEM images, TEM images at various time-points and HSI with Cytoviva.

4.2 MTS data
MTS was performed on the three types of Cu particles and CuCl2. The results of
This cellular proliferation assay can be seen in Fig 4-1.

Fig 7. MTS assay for the three types of Cu particles and CuCl2. (Concentration in µg/mL
for NPs and µM for CuCl2)
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In terms of cellular viability, CuCl2 is the least toxic at all concentrations. Cu-NP
25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and CuONP 40 nm. At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable in
toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.

From further

characterization, it is not surprising that the Cu-NP 25 nm and CuO-NP 40 nm share
similar toxicities. As these two particles become suspended in water for longer periods
of time, they both become oxidize, especially Cu-NP 25 nm, which may explain the
similarities in toxicities.

4.3 Dynamic Light Scattering Experiments
Dynamic Light Scattering Experiments were conducted in order to observe
changes in the dynamic size of Cu-NPs, CuO-NP, and Cu-MSP under cell culture
conditions.

An initial trial of DLS was conducted for the particles at 50 µg/mL

concentration with dosing media. The general conclusion is that at these conditions there
is a trend for the Cu particle sizes to increase. The surprising aspect of size observation
in solution is that it follows an inverse trend compared to the primary size of the particles:
CuO-NPs > Cu-NPs > Cu-MSPs (Schrand et al., In Preparation).
Previous studies show limited cellular modulation with co-incubation with
Dynasore. An initial experiment was conducted to serve as a control for change in
particle agglomeration for the Cu-NP (25 nm), CuO-NP (40 nm), and Cu-MSP (500 nm)
with 3, 6, and 24 hour incubation times without the use of the endocytosis inhibitor
Dynasore. Cu particles were freshly diluted from 1 mg/mL stock solutions prior to
readings. Table 6 shows concentration and incubation times. In general agglomerations

became larger as incubation time increased from 3 to 24 hours with the exception of the
Cu-NP 25 nm. Dynamic sizes of the particles under cell culture conditions are CuO-NPs
> Cu-MSPs > Cu-NPs, which is similar to the sizes measured earlier by Schrand et al.

Table 6. Concentration and incubation times used for DLS control experiment without
Dynasore
Sample
& Cu particle volume,
concentration
dosing media volume
Cu-NP (25 nm)
25 µg/mL Cu
25 µg/mL
975 µL dosing media
CuO-NP (40 nm)
25 µg/mL Cu
25 µg/mL
975 µL dosing media
Cu-MSP (500 nm)
25 µg/mL Cu
25 µg/mL
975 µL dosing media

0
hour
incubation
0
hour
incubation
0
hour
incubation
0
hour
incubation

3
hour
incubation
3
hour
incubation
3
hour
incubation
3
hour
incubation

24
hour
incubation
24
hour
incubation
24
hour
incubation
24
hour
incubation

Figures 8A, 6B, and 6C show the results of this initial DLS experiment.

Size

Cu metallic (25 nm)
2200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
0

3
Time in Hours
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24

Size

Cu Oxide (40nm)
2200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
0

3

24

Time in Hours

Size

Cu micron (500 nm)
2200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
0

3
Time in Hours

24

The next set of DLS experiments involve three trials of Cu-NP, CuO-NP, and CuMSP in dosing media at three different concentrations of 25 µg/mL, 50 µg/mL, and 100
µg/mL as seen in Table 7. Measurements were taken at 0 and 3 hours for each particle at
each concentration. 25 µM of the endocytosis inhibitor Dynasore was also added to each
sample because ultimately the goal is to understand if the chemical has any effect on the
viability of the N2A cells as seen in previous studies.

Table 7. Cu particle, Dynasore and dosing media volumes

Final concentration for
samples
25 µg/mL Cu particle +
25 µM Dynasore
50 µg/mL Cu particle +
25 µM Dynasore
100 µg/mL Cu particle +
25 µM Dynasore

Cu particle volume

Dosing Media

Total Volume

25 µL

Dynasore
volume
25 µL

950 µL

1000 µL

50 µL

25 µL

925 µL

1000 µL

100 µL

25 µL

875 µL

1000 µL

Figures 9A through 9I show size distributions from this DLS experiment.
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Size (nm)

25 ug/mL - 1st Trial + Dynasore
1600
1500
1400
1300
1200
1100
1000
900
800
700
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9A. Size distribution of Cu particles at a concentration of 25 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 1st trial

Size (nm)

25 ug/mL - 2nd Trial + Dynasore
1600
1500
1400
1300
1200
1100
1000
900
800
700
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9B. Size distribution of Cu particles at a concentration of 25 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 2nd trial

Size (nm)

25 ug/mL - 3rd Trial + Dynasore
1600
1500
1400
1300
1200
1100
1000
900
800
700
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9C. Size distribution of Cu particles at a concentration of 25 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 3rd trial

Size (nm)

50 ug/mL - 1st Trial + Dynasore
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9D. Size distribution of Cu particles at a concentration of 50 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 1st trial
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Size (nm)

50 ug/mL - 2nd Trial + Dynasore
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9E. Size distribution of Cu particles at a concentration of 50 µg/mL and
Dynasore at both 0 and 3 hours of incubation,2nd trial

Size (nm)

50 ug/mL - 3rd Trial + Dynasore
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9F. Size distribution of Cu particles at a concentration of 50 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 3rd trial

Size (nm)

100 ug/mL - 1st Trial + Dynasore
3000
2800
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9G. Size distribution of Cu particles at a concentration of 100 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 1st trial

Size (nm)

100 ug/mL - 2nd Trial + Dynasore
3000
2800
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9H. Size distribution of Cu particles at a concentration of 100 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 2nd trial
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Size (nm)

100 ug/mL - 3rd Trial + Dynasore
3000
2800
2600
2400
2200
2000
1800
1600
1400
1200
1000
800
600

25 nm Cu
40 nm Cu
400 nm Cu

0 hours

3 hours

Fig 9I. Size distribution of Cu particles at a concentration of 100 µg/mL and
Dynasore at both 0 and 3 hours of incubation, 3rd trial

4.4 LVEM Imaging
In Fig 10 A-C, LVEM images of the three particles are shown. The LVEM may
not produce the sharpest images but the process is not time consuming or difficult to set
up. From these images basic particle morphology and agglomeration behavior can be
observed.

Fig 10A. Cu-NP 25 nm at 202 kx magnification
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Fig 10B. CuO-NP 40 nm at 202 kx magnification

Fig 10C. Cu-MSP 500 nm at 202 kx magnification

4.5 ESEM Imaging
Environmental Scanning Electron Microscopy was conducted on Cu-NPs, CuONPs, and Cu-MSPs 3 months after suspension in water. The particles were diluted from
stock solutions and the goal of the microscopy was to aid in the characterization of the
physiochemical properties of the particles themselves. Examination of surface roughness
is an indicator of the amount of oxidization the particles experience and may elucidate
particle uptake sizes. Figures 11A-B illustrate the original images captured.

57

Fig 11A. Cu-NP 25 nm at 3 months

Fig 11B. CuO-NP 40 nm at 3 months

4.6 SEM Imaging
SEM images were taken after N2A cells were dosed with Cu particles in an
experiment to visually determine the placement of particles and cells in dosing media.
All particles were dosed at a concentration of 25 µg/mL. Fig 12A-D show a series of
images including a control image and that of the three particles.

Fig 12A. Control image without Cu-NPs
(Image taken by Dr. Amanda Schrand)
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Fig 12B. Cu-NP 25 nm
(Image taken by Dr. Amanda Schrand)

Although some charging is seen in the image, the Cu-NP 25 nm can be seen fairly
clearly with the N2A cells showing up as darker shadowy figures. In scanning electron
microscopy, charging effects are described where excess negative charge accumulates on
the specimens and image artifacts arise from excess surface charge and produce poor
images. At times it may be necessary to prepare poorly conducting specimens with a
metallic coating such as gold (Shaffner and Van Veld, 1971).
The control image shows the cells without any Cu NP dosing, and the cells are
observed be more adherent and neuron like with more dendrites present. As the N2A
cells are dosed with the Cu particles they are under more oxidative stress and thus start to
become rounder and less adherent to the glass cover-slip surfaces.

Fig 12C. CuO-NP 40 nm
(Image taken by Dr. Amanda Schrand)

Fig 12D. Cu-MSP 500 nm
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(Image taken by Dr. Amanda Schrand)

4.7 TEM Imaging
TEM Imaging was conducted on the Philips Lab 6 TEM at the AFRL Materials
Laboratory.

The following figures show the morphology and sizes of the particles

suspended in water: initially after preparation, at 2 or 3 months after preparation, and
again at 6 months. The surface oxidation, agglomeration, and sizes indicate changes the
particles experience over time.
It is worth noting that initial TEM imaging was conducted along with a brief
study on the size distribution of the particles. Interestingly, as was also found in the
study by Schrand et al. (In Preparation) referred to earlier, the Cu-NP 25 nm has a larger
average size than the CuO-NP 40 nm.

This is important to realize; nominal sizes

provided by the manufacturer may not be indicative of the true particle size. The stock
particles, in powder form, are preserved under Argon gas, but even so, properties of the
particles may change over time.
The three different types of particles were imaged again after 2 or 3 months to
look for any changes in oxidation, morphology, and overall surface properties. Fig 13AC show images of the three types of particles.

Fig 13A. Cu-NP 25 nm at 2 months

Fig 13B. CuO-NP 40 nm at 3 months
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Fig 13C. CuO-MSP 500 nm at 3 months

Figures 14, 15, and 16 show the comparison images of the three particles at 6
months. Comparison images were taken at standard magnifications of 3800x, 8800x,
15000x, 50,000x, and 80,000x so improved observations can be made.

Fig 14. Cu-NP 25 nm at 6 months

Fig 14A. 3800x

Fig 14B. 8800x

Fig 14C. 15,000x

Fig 14D. 50,000x
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Fig 14E. 80,000x

Fig 15. CuO-NP 40 nm at 6 months

Fig 15A. 3800x

Fig 15B. 8800x

Fig 15C. 15,000x

Fig 15D. 50,000x

Fig 15E. 80,000x
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Fig 16. Cu-MSP 500 nm at 6 months

Fig 16A. 3800x

Fig 16C. 15,000x

Fig 16B. 8800x

Fig 16D. 50,000x

Fig 16E. 80,000x

4.8

Hyperspectral Imaging
Hyperspectral Images and spectra.

Fig 17A. HSI image of Cu-NP 25 nm with Spectral Profile.
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Fig 17B. HSI image of CuO-NP 40 nm with Spectral Profile

Fig 17C. HSI image of Cu-MSP 500 nm with Spectral Profile

Unfortunately, it was also shown that copper does not have a “prominent lightscattering or absorption peak in the visible region of the spectrum” (Yguerabide and
Yguerabide, 1998). This makes it very difficult to draw any conclusions from the HSI
data as there is not a clear plasmonic peak for copper and the collected spectra of

dissimilar sizes of copper nano and micron-sized particles would not give much
information.
Careful inspection of the three spectral profiles shows that there are very broad
peaks and it is difficult to pinpoint any specific peaks. From chapter 3, Yguerabide and
Yguerabide (1998) show that the copper band should fall somewhere between 380-530
nanometers, yet these spectra show broad bands between 500-800 nanometers. This
could be due to agglomeration of the particles but regrettably no additional information is
provided such as oxide content between the various particles as no clear “shift” can be
observed.
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V. Conclusions and Future Research Considerations
5.1 Overview
This chapter summarizes the results of this research and suggests additional
studies that may aid to further characterize Cu-NPs, Cu-MSPs and CuO-NPs.
Suggestions for methodology improvements are discussed as well as further additional
research that may aid in better characterization.

5.2 Conclusions
This research compared the effects upon N2A cellular viability by the three types
of Cu particles and characterized these particles using a variety of techniques. Toxicity
changed for the N2A cells at different concentrations and for different particles. At high
concentrations, N2A cells fared better when dosed with Cu-MSP 500 nm. This may be
related to cellular mechanisms where cellular uptake is generally limited for large
particles around 500 nm, thus enabling smaller Cu particles to be uptaken easier.
Characterization showed a general increase in size when the particles were incubated
with the endocytosis inhibitor Dynasore. This may also explain apparent “rescue” effects
seen in previous research, where there was increased cellular viability in the presence of
Dynasore. At higher concentrations of particles (100 µg/mL) with 25 µM Dynasore
trends are somewhat more inconclusive, suggesting possible interferences in the solution
or between the particles themselves as far as forming agglomerations.
Additionally, this research seeks to observe in vitro effects upon murine
neuroblastoma cells (N2A) by these three types of particles as well as by CuCl2.
Microscopy techniques indicate observable changes in oxidation for Cu-NP 25 nm and

CuO-NP 40 nm after suspension in water over long incubation.

In general,

agglomerations of the particles increase when dosed with the endocytosis inhibitor
Dynasore. In terms of cellular viability, CuCl2 is the least toxic at all concentrations.
Cu-NP 25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and
CuO-NP 40 nm. At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable
in toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.

5.2.1

Imaging

Various techniques for imaging cells and toxicity studies were conducted with the
nano and micron-sized particles. A general rough estimate of sizes and morphology was
conducted with the LVEM. More detailed imaging was conducted with the ESEM and
SEM.

Finally the high resolution TEM was used to look at changes in surface

morphology, oxidation and size over time.

DLS was also used to estimate the

agglomeration of the particles while dark field microscopy with Cytoviva as a light
source provided insight on particle uptake and provided particle spectral profiles. Each
of these techniques was useful in directing the focus of this research and providing
insights, but each technique also had its own limitations.
The ESEM imaging, though not very successful, was used to gain more
information on general particle morphology. Image quality and instrument availability
was problematic, but a few images did show likely nanoparticle agglomerations on the
surface of the ESEM stub. Additional technique modifications with ESEM may be
helpful for future research.

SEM imaging with the cells gave good morphological

indications of healthy cells as more rounded than those receiving increasing doses of Cu
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particles and proved qualitatively that the technique worked well. TEM imaging, though
the most time consuming and very difficult to schedule for, was critical in determining
particle morphology and had the best results. Previous studies show very low, if any Cu
particle uptake into N2A cells and future studies may be needed in order to determine
particle locations in respect to the N2A cells and overall changes in N2A morphology
after Cu particle exposures (Schrand, In Preparation).

5.3 Recommended Additional Research

5.3.1

Characterization and Exposure

Characterization may have been affected by other experimental conditions that
may have interfered with the results. Vortexing of the particles was consistent prior to
dosing or experimentation, but sonication of the particles was not. Sonication of particles
may have immense effects on their properties so sonication should be conducted more
carefully and consistently in the future.
Other techniques that are emerging such as the separation of the Cu metal and the
Cu ions can prove to be helpful in determining whether the cellular toxicity is due to the
actual metal or the corresponding ions.

This will also enable other techniques to

determine the quantity of Cu that is released into the cell medium for exposure studies.
More repetitions on the DLS can be conducted to try to find better trends in
particle agglomeration sizes and behaviors in solution.

The endocytosis inhibitor

Dynasore previously demonstrated to increase cellular viability is still inconclusive and
need to be further explored as to exactly what are the potential mechanisms for reducing
cytotoxicity for N2A cells.

Appendix A: General Maintenance and Toxicity Testing of N2A Cell Line
(Schrand & Hussain, 2005)

PURPOSE/PRINCIPLE: This standard operating procedure describes the in vitro
methods for maintaining N2A (neuroblastoma cells) for toxicity testing procedures
including formulations for MTS.

KEY WORDS: N2A, neuroblastoma, cell culture, in vitro, nanotoxicity.
1.

SAFETY AND OPERATING PRECAUTIONS:
1.1

Practice aseptic technique and work with all cells and solutions under the
biological hood.

1.2

Wear appropriate gloves, eye goggles and lab coat when handling
hazardous materials.

1.3
2.

Properly dispose of unused/spent toxic materials (nanoparticles).

EQUIPMENT/MATERIALS/REAGENTS:
2.1

Culture media (DMEM/F12 (Sigma powder), 10% fetal bovine serum
(FBS), and 1% antibiotics (Pen/Strep)
*Note: discard if pink (too acidic) or orange (too basic)…should be
red/orange in color

2.2

Flasks, plates, slides for growing cells

2.3

Trypsin for detaching adherent cells

2.4

Acidified IPA with 70% isopropanol for dissolving cells
300mL 70% IPA and 1.64mL conc. HCl
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2.5

MTS (C18H16N5SBr, Cat#M2128 Sigma)
200 mg MTS (in freezer, Rm 169), 40ml PBS, mix on stir plate for ~15
minutes, store covered in foil due to light sensitivity, dated, good for 2-4
weeks

2.6

Nanomaterials with a known concentration typically diluted in water for a
stock solution of concentration 1-10 mg/ml

2.7

Olympus IX71 Inverted Microscope with 12 bit QICAM from IMAGINE
(Lab 160)

SPECIMEN/SAMPLE: Seed cells at high enough density to achieve 80% confluency
by time of treatment. For example, if you are seeding on Friday and want to treat
on Monday (3 days of growth time), seed at 200-300K cells/mL. If you are
seeding on Monday and want to treat on Tuesday (24h of growth time), seed at
500-600+ K cells/mL. For better imaging conditions of individual cells, seed at
100-250K cells in 1 mL of culture media.
*Note: Check cells before dosing to optimized for your cells. If you are
performing an MTS assay and you expose them before they are confluent, your
“intensity” of blue color will be very low and you won’t get readings. The more
cells you have, the more “blue” will develop/stronger your “signal.”
3. PASSAGING CELLS
4.1 Use 1-2 mls of 1% trypsin to release cells from the bottom of cell culture
flasks. Avoid tapping if clumps form.
*Note: N2A cells are a mixture of floating and adherent cells

4.2 Add 5-10 mls of growth media containing serum to neutralize the effect of
the trypsin and transfer this solution to a conical vial before performing a cell
count.
4.3 To get an average cell count, 10 µl of cells in media were added to a
hemocytometer slide. This slide contains numerous grids that are used to help
count cells. The cells located in the grids on each corner of the slide are counted,
and the average number of cells in each grid is determined to be the number of
cells per 10 µl and, by multiplying that number by 10,000, the number of cells per
mL is determined. The total number of cells in a sample can be determined by
multiplying the cells/mL by the number of mL in the sample. The concentration
can be adjusted down by diluting the sample, using the following equation
Cinitial x Vinitial = Cdesired x Vdesired.
4.4 Based on cell count add media to the cell suspension to obtain the desired
number of cells for the flask, plate, or slide, then add the correct amount of
solution to each well/slide.
4.5 From the remaining solution, add 1mL of cell suspension to a new flask
containing ~10-12mL media for re-growth, then return the flask to the incubator
4.6 Change media and reduce cell count every 2-4 days
5. NANOPARTICLE DOSING PROCEDURE:
5.1 Make nanoparticle dosing concentrations from stock concentrations of
nanoparticles in water into fresh in DMEM/F12 media without serum. If you
want to obtain images of these dosing solutions, use 15 mL conical tubes, small
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clear plastic eppendorf tubes, or glass vials. Before dosing, mix the solutions well
by vortexing and pipetting.
5.2 N2A cells are typically dosed 24 hours after seeding as described in Section 4
for passaging the cells. The existing growth media is aspirated prior to the
addition of nanoparticle solutions.
5.3 Doses for nanoparticles are typically 0, 5, 10, 25, 50, 100 µg/ml. Doses for
bulk materials are typically lower such as AgNO3: 0, 0.5, 1, 2.5, 5, 10µg/ml or
Mn acetate: 0, 1, 2.5, 5, 10, 25µg/ml. For 6-well plates, 1ml of dose per well, for
12 or 24-well plates, 0.5ml of dose per well. A typical 6-well plate set up is as
follows:
0 (control)

Conc. 1

Conc. 2

Conc. 3

Conc. 4

Conc. 5

Perform assay in triplicate (3 plates each).
5.4 After dosing, label wells with dose and label plate with material used and the
time, then return plates to incubator
5.5 Following 24 hours (or other time point eg. 12, 48 etc) assay plates for
determined endpoint (MTS, LDH, etc)
6. MTS ASSAY OF VIABILITY
6.1 Following exposure interval, do NOT aspirate media. Add MTS stock
directly to each well:
6 well plates = add 200 µl of MTS 5 mg/ml stock soln.
12 well plates = add 100-150 µl of MTS 5 mg/ml stock soln.

24 well plates = add 100 µl of MTS 5 mg/ml stock soln.
96 well plates = add 200 µl of MTS 5 mg/ml stock soln.
6.2 Incubate at 37° C in incubator until color develops (usually 30 minutes or may
be longer)
6.3 Remove the MTS solution and lyse cells with 0.5 ml acidified isopropanol
solution (acidified IPA) solution to well and place on a stir plate for
approximately 30 minutes.
6.4 Remove the solutions and place into eppendorf tubes to vortex to obtain
homogeneous staining of the formazan crystals
6.5 Centrifuge the purple solution at high speed to spin out nanoparticles.
6.6 Transfer 200 ul of samples into wells of 96 well plate in duplicate or greater
6.7 Read plates at 570 nm minus 630 nm on a microplate reader
6.8 For the Molecular Devices SpectraMax190, follow the instructions below:
Start, Programs, Softmax 3.1, Spf (click), open old file, click template, highlight
old data, clear, highlight cells, enter group name ie. control, what it is, sample 0,
25, etc. for concentrations Turn on microplate reader machine (needs a minute to
calibrate), drawer will open, snap plate in place, click read, normal, ok, replace.
Turn off microplate reader and log-out/turn off computer. Throw away materials
into red trash can for biohazard.
6.9 MTS DATA ANALYSIS/RECORDS:
CT = 100 * ((ODt/ODc)
CT = % of MTS reducing activity
ODt= Optical Density of treated samples
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ODc= Optical Density of control
7. IMAGING FOR NANOPARTICLE UPTAKE
7.1 After plating and dosing cells as described above, remove nanoparticles and
wash 1-2X with PBS if necessary.
7.2 Remove the chambers from slide if necessary and mount with a coverslip,
then seal edges with clear nail polish
7.3 Mount slide inverted onto microscope, then focus image.
7.4 Once your image is in focus through the microscope binocular lenses, start
the QCapture program. Press the camera icon, then preview. To adjust the
brightness of the image, change the exposure slide bars. After your preview
image is adjusted for focus and brightness, make sure acquisition is set to 1x1, 8bit B&W, or 24 bit RGB, then press snap to capture image. Go to File, Save as to
save image. Do not use any symbols including periods in your file name and save
original files as tif.
7.5 To add scale bars, press the micrometer icon and select the appropriate
magnification. For 20x images, use 20 micron bar, for 60x images, use
100 micron bar. Right click to burn micron bar onto file.
8.

QUALITY CONTROL
7.1

Use a positive and negative control, examine cells for viability

(ie. Control with no nanoparticles and toxic material such as AgNO3 or
CdO).

LIMITATIONS OF PROCEDURE:

8.1 This procedure can be slightly modified for non-adherent cells and cellspecific media should be used.
9.

PROCEDURE NOTES: Too many or two few cells may skew the results of the
MTS assay.
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Appendix B – Basic N2A Cell Maintenance
1. Spray alcohol on gloves and on the work space area in the hood to avoid
contamination!
2. Cells are observed under light microscope to see how healthy they look and whether
they are becoming fairly confluent (getting crowded). If this is the case then it is time to
split them or plate them.
3. Aspirate old media with the vacuum but be careful not to remove the cells that are
adherent to the flask.
4. Add new GROWTH media (~5-10mL). This is the DMEM F12K Ham's + 1%
pen/strep AND 10% FBS.
5. Scrape the bottom gently with a cell scrape to remove cells that are sticking to the
bottom.
6. Mix the media around and then put all of the media along with the cells into a conical
vial with the 10mL glass pipette. A 50mL conical vial usually works well for holding the
media with the cells.
7. If cells are needed to plated at a certain density, the Nexcelom Bioscience’s Cellometer
Vision was used for automated cell counts. Dilutions can be easily calculated to plate at
desired densities.
8. Add desired mL of cells into each container (flask, 96-well plate, chambered slides,
etc). For 96-well plates, 200uL is added per well with a multi-chambered pipette. 1mL
of cell solution is added per chamber. Leftover cell solution is divided into the T-75
flasks for continued growth. Cells can be diluted with extra growth media. If cells are

only split, extra cells can be discarded or put into another T-75 flask for growth9. For
flasks, make sure to add enough growth media so that each one has ~10-15mL.
9. Be sure to observe the cells under the light microscope after they are put into the
flasks. They will not have adhered to the bottom of the flasks yet so they will look
rounder. Cells need to stay as healthy as possible for experiments. They will most likely
need to be split about every 3 days. Beyond this they may become too confluent and thus
less healthy.
10. Put everything back into the incubator and close the inner door securely.
12. Remember that the cells are can never exposed to the air unless they are in the hood.
Be sure to cover the 96 well plate, screw the cap on the flasks, etc. All other pipettes and
cell scrapers must all be opened in the hood.
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Appendix C: Operating instructions for the LVEM
(Schrand & Hussain, 2010).

PURPOSE/PRINCIPLE: This standard operating procedure describes methods for
using the Low Voltage Electron Microscope (LVEM).
KEY WORDS: Nanoparticle agglomeration, Cell uptake
1.

2.

SAFETY AND OPERATING PRECAUTIONS:
1.1

Wear appropriate gloves when handling samples/sample holder.

1.2

Properly dispose of unused/spent toxic materials (nanoparticles).

EQUIPMENT/MATERIALS:
2.1

Cu TEM grids, preferably carbon-coated or uncoated

2.2

Nanoparticles in solution (typically water or ethanol)

4. PROCEDURE:
4. 1
Prepare samples on TEM grids by drop-casting solution with
micropipetter onto Whatman’s filter paper to remove excess solution (typically
NP solution concentrations should be ~50 µg/ml for ease in finding NPs). Store
in grid box until ready to image.
4.2

IP switch remains ON, do not turn this off.

4.3

Turn on the microscope (MIC) switch.

4.4

Turn on the camera (top of camera has its own switch)

4.5

Turn on turbo pumps (PS).

4.5

Open software on computer by double-clicking icon.

4.6

Log in with username and password: guest, guest on computer and sign in
log book with Name, Date, Time, Initial ip1 and ip2 values.

4.7

Wait for vacuum pump LED to change from red/orange to GREEN

4.8

If sample holder left in LVEM, pull straight out---this is the preferred
storage location for sample holder. You should see little nub on holder
before pulling out. (if not please find Amanda for further instruction)

4.9

Insert TEM grid into holder with provided sample holder carrier by gently
lifting Cu flap and replacing it with fine tweezers.

4.10

Re-insert sample holder into LVEM by pushing straight back. Turn
airlock to GREEN tape (open). Wait for LED light to turn GREEN, then
continue to insert sample by turning holder 45º clockwise and slowly
pushing in (requires some force). Watch ip1 values (sample chamber ip
current). These must be in black before HV turned on (Step 4.13)

4.11

Fasten silver knob until tight (do not over tighten), then press in black
knob at the end of the sample holder.

4.12

Turn on electron gun (HV) on the black console and notice that small
RED light comes on at the top of the sample chamber. WAIT ~ 15
minutes for gun emission to stabilize to 5.4 kV (Preset). With objective
lenses out of the way of the YAG screen, you should be able to see a dot
indicative of the electron beam. If not, adjust HV (~5.15kV) and move
sample with joystick on black console until a dot is present in the center of
the YAG screen.

4.13

Turn objective lens to 4x objective, then click VIEWS, CAMERA,
START/STOP from software menu to view beam on the computer screen.
Spread beam out by adjusting HV, gain (ie. 500). *Make sure camera
was turned on at the top of the LVEM and that the pull out knob on
the side of the camera is all the way out.

4.14

For an overview of the sample, select MODE, SCAN MODE. For TEM,
change to MODE, TEM. To change magnification, use black knob on
console. To adjust focus, use HV and Z height adjustment on sample
stage as well as the YAG dial. *It may be easier to start focusing on the
edge of the grid.

4.15

TO CHANGE/REMOVE SAMPLE: Turn off HV, unscrew silver knob,
pull sample holder straight out, CAREFUL HERE: turn sample holder
30º (you should see small silver knub in sample exchange area), close
off valve (you should see orange tape), LED should be GREEN, pull
holder straight out, remove sample from sample holder and place in grid
box for storage)

4.16

TO REINSERT NEW SAMPLE: Ensure that LED light is GREEN, then
start at step 4.10 above. *Make sure that LED light is GREEN, no HV
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is on (there is NO small red light on above sample chamber) before
proceeding with sample insertion.
4.17

SHUT DOWN: Remove sample from holder as described in step 4.15 and
place grid for storage in grid box. Push sample holder (without any
sample in it) into sample chamber for storage, *HV must be turned OFF,
you should see orange tape indicating that vacuum valve is CLOSED,
turn off MIC and PS, turn off camera at top of microscope, close
software, touch computer screen for screen-saver mode.

RECORDING IMAGES/SAVING FILES:
5.1

In the VIEWS, CAMERA, START/STOP, select CAPTURE IMAGE to
take a final picture, then select where you want to save file in your user
folder. Keep the magnification as part of the image if you want to calibrate
for size measurements later on (See attachment on QCapture Pro Software
to make measurements on image).

QUALITY CONTROL:
7.1
Check with Amanda on beam alignments when sample is removed for
correct position/stigmatism.
LIMITATIONS OF PROCEDURE:
8.1 Very small nanoparticles, thick sections and coated grids may pose
imaging problems in LVEM. No samples can be wet.
9.

PROCEDURE NOTES:

10. REFERENCES:
11. ATTACHMENTS:
Attachment 1: About the LVEM System
Attachment 2: QCapture Pro Software for Measuring Images

ATTACHMENT 1: About the LVEM System

ATTACHMENT 2: QCapture Pro 6.0 Software for Measuring Images
1. Turn on computer.
2. Switch camera on (black switch on top of camera).
2. Open the QCapture Pro 6.0 software.
4. File, open, desktop, user files, select folder/file and open
5. To measure, select measure on menu bar, calibration, calibration wizard, calibrate
active image, LVEM_TEM mode_mag, nanometers, next, draw reference line, “1000”
or other units to match current micron bar on image
6. Check your calibration with Calibration, select spatial, marker, move, right click to
burn to image
7. To make measurements, select Measure, measure distances, measure the area on
image, then under the Measure menu select snap measurements to burn them to image,
then file save as (rename with _measured or other label to distinguish from original
file).
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Appendix D: Checklist for the Transmission Electron Microscope – CM 200 Lab 6
Provided by Dr. Robert Wheeler, modified by Capt S. V. Brownheim
The TEM at Lab 6 at the Materials Lab is a 200 kV TEM
1.
2.
3.
4.
5.

Make sure panel lights are on – two LEDs should be on: UHV and HVAC
Check the system vacuum, make sure IGP < 20, P3 < 70
High Tension (HT) = 200 kV?
LN2 – Liquid nitrogen should be filled in the canister and coils remain cooled
Load TEM specimen with correct tools onto appropriate sample holder, check for
dust particles on O-ring and clean as necessary
6. Load TEM sample holder along with specimen in the following way:
a. Check vacuum again
b. Start inserting sample with the small pin pointed in the 3 o-clock position
while inserting the rod as straight as possible
c. A “catch” should be felt and the vacuum pump should start pumping, the
red light should turn on near the sample holder
d. Spin from the 3 o-clock position to the 5 o-clock position and gently put
the sample holder into the recess
e. Select the correct holder on the screen, connect the plug, and press “ready”
f. When the vacuum stops pumping the red light should go out
g. Starting “opening” the sample, waiting for IGP to jump and then stabilize
h. Wait for equilibration, then completely open and feed the sample holder
the rest of the way in until secured
i. Specimen is now loaded
7. C2 Aperture - using the top aperture to adjust and center the maximum
illumination from the electron beam possible
8. Eucentric Height (Objective Lens should equal 5480) – adjust by using “step” size
knobs
9. Gun Tilt – make the illumination as bright as possible
10. Gun Shift
11. Pivot Points
12. Rotation Alignment – press the “ROT CENTER” button to optimize image and
make the image move the least amount possible
*The image on the next page shows the control panels on the TEM
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Appendix E: Cell Sample Preparation for the Scanning Electron Microscope
(Schrand, 2006).

1. Allow sufficient time to start and complete protocol. Typically, the fixation and
dehydration take half of a day and then the cells are left overnight. The next day, drying,
mounting, coating, and imaging would require an additional 3 or more hours.
2. Grow cells on Aclar polymer discs or other surface in multi-well dishes according to
standard cell culture techniques.
3. Remove growth medium and wash 2X each for 10 minutes with PBS.
4. Add glutaraldehyde/Na cacodylate solution (2.5% glut/form in 0.1M Na caco pH 7.4)
at 4 °C for 1 hour to fix.
5. Remove fixative and wash 3X each for 15 minutes with 0.1 M Na caco buffer, pH 7.4
(dilute 0.2M in half with double distilled deionized water).
6. Remove buffer and start dehydration series (50, 70, 90, 100, 100, 100, 100%) in
ethanol for 15 minutes each, then leave in fresh 100% ethanol overnight in a closed dish
to prevent evaporation.
7. Transfer cells in multiwell plates in 100% ethanol to the NEST at UD.
8. Critical Point dry and mount to SEM stub with double-sided carbon tape.
9. Coat with gold in sputter coater.
10. Image in High Resolution SEM (make sure that you have been properly trained or a
staff person is available to assist you on the instrument. Once you are trained, the time
can be scheduled online at www.nestlaboratory.com before showing up for your session).

Appendix F: Operating Instructions for Malvern’s Zetasizer for Dynamic Light
Scattering (DLS)

1. Log on to DLS computer.
2. Open Zetasizer software and click on “manual measurement”, ensuring proper
settings are set and select the correct sample holder. For zeta potential
measurements the clear zeta cuvette must be selected. Select either “size” or
“zeta potential” to run with.
3. Vortex sample.
4. Close cuvette with the appropriate tops and insert into cuvette holder.
5. Click the measure button.
6. Measurement records are saved automatically in the main record area under the
file name. Data can be exported to Microsoft Excel or Microsoft Word.
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Appendix G: Hyperspectral Imaging

Olympus IX71 Inverted Fluorescent Microscope with CytoViva 150 attachment and 12 bit
QICAM from IMAGINE (Lab 160)

VNIR Hyperspectral Imager
Imaging Camera
Hyperspectral Data
150w Halogen
Light Source

Dual Mode Fluorescence Module

Cytoviva Equipped
Optical Microscope

Optical Image

HSI system set up, picture from the manufacturer (Cytoviva, 2011).
http://www.cytoviva.com/product_hyperspectral_imaging.htm
1. Samples of the N2A cells or particles are dropped onto glass slides. Cells are
covered with a glass cover-slip and sealed around the edges with nail polish. Care
is taken to ensure there’s not too much cell solution on the glass slide. Particles at
the desired concentration are dropped onto the glass slides and allowed to dry
under the hood. Glass cover-slips are added and the edges are sealed with nail
polish.
2. Once the sample slides are prepared the HSI system was used to capture the
images of the samples and appropriate spectra are captured.
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